Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Visudyne submitted for marketing approval in Canada

Nov. 8, 1999

Mycophenolate mofetil in the treatment of refractory uveitis

Oct. 28, 1999

AGN-192024 is better than latanoprost for lowering diurnal IOP

Oct. 28, 1999

Nonpeptide integrin antagonists from DuPont and use for inhibiting cell adhesion

Oct. 25, 1999

Alphagan safely and effectively lowers IOP in glaucoma patients

Oct. 25, 1999

News from AAO/PAAO joint meeting: droperidol may be indicated for glaucoma

Oct. 25, 1999

Development status update for antiglaucoma drug candidate

Oct. 22, 1999

Verteporfin prevents vision loss in AMD patients with predominantly classic CNV lesions

Oct. 19, 1999

Preclinical results indicate a new target for RP therapy: calcium channel blockade

Oct. 18, 1999

FDA advisory committee to review Visudyne NDA

Oct. 8, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...